Related references
Note: Only part of the references are listed.Absence of the Vitamin D Receptor Inhibits Atherosclerotic Plaque Calcification in Female Hypercholesterolemic Mice
Sohel Shamsuzzaman et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation
Lynett Danks et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL
M. Onal et al.
ENDOCRINOLOGY (2016)
Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice
Melda Onal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
Jian Luo et al.
NATURE MEDICINE (2016)
Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
Gregory A. Roth et al.
CIRCULATION (2015)
OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism
Laleh Ardeshirpour et al.
ENDOCRINOLOGY (2015)
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System
Matteo M. Guerrini et al.
IMMUNITY (2015)
A DNA Segment Spanning the Mouse Tnfsf11 Transcription Unit and Its Upstream Regulatory Domain Rescues the Pleiotropic Biologic Phenotype of the RANKL Null Mouse
Melda Onal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Transcriptional Regulation of the Human TNFSF11 Gene in T Cells Via A Cell Type-Selective Set of Distal Enhancers
Kathleen A. Bishop et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
The immune system, bone and RANKL
Matteo M. Guerrini et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Mouse and Human BAC Transgenes Recapitulate Tissue-Specific Expression of the Vitamin D Receptor in Mice and Rescue the VDR-Null Phenotype
Seong Min Lee et al.
ENDOCRINOLOGY (2014)
The RUNX2 Cistrome in Osteoblasts CHARACTERIZATION, DOWN-REGULATION FOLLOWING DIFFERENTIATION, AND RELATIONSHIP TO GENE EXPRESSION
Mark B. Meyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Peter Libby
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
Belinda A. Di Bartolo et al.
PLOS ONE (2013)
Epigenetic Control of Smooth Muscle Cell Differentiation and Phenotypic Switching in Vascular Development and Disease
Matthew R. Alexander et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 74 (2012)
Enhanced Mineralization Potential of Vascular Cells from SM22α-Rankl tg Mice
S. Morony et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study
Veena Naik et al.
CARDIOVASCULAR RESEARCH (2012)
Smooth Muscle Cell-Specific Runx2 Deficiency Inhibits Vascular Calcification
Yong Sun et al.
CIRCULATION RESEARCH (2012)
RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation
Estelle Hess et al.
JOURNAL OF IMMUNOLOGY (2012)
RANKL Enhances Macrophage Paracrine Pro-Calcific Activity in High Phosphate-Treated Smooth Muscle Cells: Dependence on IL-6 and TNF-α
Kate Ann Deuell et al.
JOURNAL OF VASCULAR RESEARCH (2012)
No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells
Malene Olesen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
The RANKL Distal Control Region Is Required for the Increase in RANKL Expression, But Not the Bone Loss, Associated with Hyperparathyroidism or Lactation in Adult Mice
Melda Onal et al.
MOLECULAR ENDOCRINOLOGY (2012)
Arterial calcification and bone physiology: role of the bone-vascular axis
Bithika Thompson et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages
Chang Hyun Byon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Catherine M. Shanahan et al.
CIRCULATION RESEARCH (2011)
The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
Agbor Ndip et al.
DIABETES (2011)
Mouse Rankl Expression Is Regulated in T Cells by c-Fos through a Cluster of Distal Regulatory Enhancers Designated the T Cell Control Region
Kathleen A. Bishop et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Soft Bone - Hard Arteries: A Link?
Gerard M. London
KIDNEY & BLOOD PRESSURE RESEARCH (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
A shift in calcium
Sundeep Khosla
NATURE MEDICINE (2011)
Matrix-embedded cells control osteoclast formation
Jinhu Xiong et al.
NATURE MEDICINE (2011)
Estrogen Inhibits Vascular Calcification via Vascular RANKL System Common Mechanism of Osteoporosis and Vascular Calcification
Mariana Kiomy Osako et al.
CIRCULATION RESEARCH (2010)
Increased PTHrP and Decreased Estrogens Alter Bone Turnover but Do Not Reproduce the Full Effects of Lactation on the Skeleton
Laleh Ardeshirpour et al.
ENDOCRINOLOGY (2010)
Inflammation and the Osteogenic Regulation of Vascular Calcification A Review and Perspective
Jian-Su Shao et al.
HYPERTENSION (2010)
PKA-induced Receptor Activator of NF-κB Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix Calcification
Wendy Tseng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulatory mechanisms in vascular calcification
Andrew P. Sage et al.
NATURE REVIEWS CARDIOLOGY (2010)
Inhibition of Receptor Activator of NF-κB Ligand by Denosumab Attenuates Vascular Calcium Deposition in Mice
Susann Helas et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4-Dependent Pathway
Sara Panizo et al.
CIRCULATION RESEARCH (2009)
Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries
Mei Y. Speer et al.
CIRCULATION RESEARCH (2009)
The emerging role of phosphate in vascular calcification
Cecilia M. Giachelli
KIDNEY INTERNATIONAL (2009)
A Novel Distal Enhancer Mediates Cytokine Induction of Mouse Rankl Gene Expression
Kathleen A. Bishop et al.
MOLECULAR ENDOCRINOLOGY (2009)
Central control of fever and female body temperature by RANKL/RANK
Reiko Hanada et al.
NATURE (2009)
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vitamin D and osteogenic differentiation in the artery wall
Jeffrey J. Hsu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappa B ligand gene reduces bone remodeling and increases bone mass
Carlo Galli et al.
ENDOCRINOLOGY (2008)
Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway
B. G. Choi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-κB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3
Robert D. Nerenz et al.
MOLECULAR ENDOCRINOLOGY (2008)
Aortic Msx2-Wnt calcification cascade is regulated by TNF-α-Dependent signals in diabetic Ldlr-/- mice
Ziyad Al-Aly et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Cristina Sobacchi et al.
NATURE GENETICS (2007)
Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease
Stefan Kiechl et al.
CIRCULATION (2007)
The vascular biology of calcification
Rukshana C. Shroff et al.
SEMINARS IN DIALYSIS (2007)
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Karin Loser et al.
NATURE MEDICINE (2006)
Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification
Yin Tintut et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2006)
Parathyroid hormone controls receptor activator of NF-κB ligand gene expression via a distant transcriptional enhancer
Qiang Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Activation of receptor activator of NF-κB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers
Sungtae Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Enhanced T-cell expression of RANK ligand in acute coronary syndrome -: Possible role in plaque destabilization
WJ Sandberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Distribution of coronary artery calcium by race, gender, and age - Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
RL McClelland et al.
CIRCULATION (2006)
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE(-/-) mice
Brian J. Bennett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Monckeberg's sclerosis and atherosclerosis
M Schoppet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Vascular calcification mechanisms
CM Giachelli
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulate aortic valve calcification
JJ Kaden et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads
TM Doherty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Bone formation in carotid plaques - A clinicopathological study
JL Hunt et al.
STROKE (2002)
Smooth muscle cell phenotypic transition associated with calcification - Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers
SA Steitz et al.
CIRCULATION RESEARCH (2001)
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques
CR Dhore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis
P Collin-Osdoby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study
DP Kiel et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
JE Fata et al.
CELL (2000)
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene
N Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis
H Min et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Prostaglandin E2 induces expression of receptor activator of nuclear factor-κB ligand/osteoprotegrin ligand on pre-B cells:: Implications for accelerated osteoclastogenesis in estrogen deficiency
M Kanematsu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
